Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arka De

Showing results (131-140 of 141) with videos related to

Pageof 15
Sort By:
Indian Dermatology Online Journal|January 24, 2025
Consensus Based Indian Guidelines for the Management of Pemphigus Vulgaris and Pemphigus FoliaceousDipankar De, Hitaishi Mehta, Shikha Shah, et al.
Alimentary Pharmacology & Therapeutics|February 2, 2024
Machine learning improves the prediction of significant fibrosis in Asian patients with metabolic dysfunction-associated steatotic liver disease - The Gut and Obesity in Asia (GO-ASIA) StudyNipun Verma, Ajay Duseja, Manu Mehta, et al.
Journal of Clinical and Experimental Hepatology|March 23, 2023
Indian National Association for Study of the Liver (INASL) Guidance Paper on Nomenclature, Diagnosis and Treatment of Nonalcoholic Fatty Liver Disease (NAFLD)Ajay Duseja, S P Singh, Arka De, et al.
Journal of Clinical and Experimental Hepatology|June 19, 2025
Adoption of the New Nomenclature of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) by the Indian National Association for Study of the Liver (INASL): Implications for the INASL Guidance Paper on NAFLDAjay Duseja, Arka De, Shivaram P Singh, et al.
Alimentary Pharmacology & Therapeutics|May 13, 2026
Epidemiology, Predictors of Antimicrobial Resistance and Empiric Treatment Strategies for Spontaneous Bacterial Peritonitis in Cirrhosis: A Multicentre SBP-INDIA StudyNipun Verma, Rohit Mehtani, Arun Valsan, et al.
Journal of Clinical and Experimental Hepatology|February 12, 2026
Type 2 Diabetes Mellitus and Risk of Advanced Fibrosis in Patients With Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD): The Results of Multi-centre Indian Consortium on MASLD (ICOM-D) StudyNarendra S Choudhary, Ajay Duseja, Arka De, et al.
Hepatology International|May 26, 2023
Asia-Pacific association for study of liver guidelines on management of ascites in liver diseaseVirendra Singh, Arka De, Rohit Mehtani, et al.
Journal of Clinical and Experimental Hepatology|March 4, 2026
Indian National Association for Study of the Liver Guidance Document on Difficult to Treat Autoimmune HepatitisSunil Taneja, Akash Roy, Rohit Mehtani, et al.
Indian Journal of Gastroenterology : Official Journal of the Indian Society of Gastroenterology|May 25, 2026
Exploring role of therapeutic plasma exchange for hepatitis A-related acute liver failure: An Indian multi-center cohort studyAsisha M Janeela, Ajay Duseja, Arun Valsan, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|September 24, 2020
Impact of metabolic risk factors on the severity and outcome of patients with alcohol-associated acute-on-chronic liver failureAjay Duseja, Arka De, Sunil Taneja, et al.
Pageof 15

Showing results (131-140 of 141) with videos related to

Sort By:
Pageof 15
Indian Dermatology Online Journal|January 24, 2025
Consensus Based Indian Guidelines for the Management of Pemphigus Vulgaris and Pemphigus FoliaceousDipankar De, Hitaishi Mehta, Shikha Shah, et al.
Alimentary Pharmacology & Therapeutics|February 2, 2024
Machine learning improves the prediction of significant fibrosis in Asian patients with metabolic dysfunction-associated steatotic liver disease - The Gut and Obesity in Asia (GO-ASIA) StudyNipun Verma, Ajay Duseja, Manu Mehta, et al.
Journal of Clinical and Experimental Hepatology|March 23, 2023
Indian National Association for Study of the Liver (INASL) Guidance Paper on Nomenclature, Diagnosis and Treatment of Nonalcoholic Fatty Liver Disease (NAFLD)Ajay Duseja, S P Singh, Arka De, et al.
Journal of Clinical and Experimental Hepatology|June 19, 2025
Adoption of the New Nomenclature of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) by the Indian National Association for Study of the Liver (INASL): Implications for the INASL Guidance Paper on NAFLDAjay Duseja, Arka De, Shivaram P Singh, et al.
Alimentary Pharmacology & Therapeutics|May 13, 2026
Epidemiology, Predictors of Antimicrobial Resistance and Empiric Treatment Strategies for Spontaneous Bacterial Peritonitis in Cirrhosis: A Multicentre SBP-INDIA StudyNipun Verma, Rohit Mehtani, Arun Valsan, et al.
Journal of Clinical and Experimental Hepatology|February 12, 2026
Type 2 Diabetes Mellitus and Risk of Advanced Fibrosis in Patients With Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD): The Results of Multi-centre Indian Consortium on MASLD (ICOM-D) StudyNarendra S Choudhary, Ajay Duseja, Arka De, et al.
Hepatology International|May 26, 2023
Asia-Pacific association for study of liver guidelines on management of ascites in liver diseaseVirendra Singh, Arka De, Rohit Mehtani, et al.
Journal of Clinical and Experimental Hepatology|March 4, 2026
Indian National Association for Study of the Liver Guidance Document on Difficult to Treat Autoimmune HepatitisSunil Taneja, Akash Roy, Rohit Mehtani, et al.
Indian Journal of Gastroenterology : Official Journal of the Indian Society of Gastroenterology|May 25, 2026
Exploring role of therapeutic plasma exchange for hepatitis A-related acute liver failure: An Indian multi-center cohort studyAsisha M Janeela, Ajay Duseja, Arun Valsan, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|September 24, 2020
Impact of metabolic risk factors on the severity and outcome of patients with alcohol-associated acute-on-chronic liver failureAjay Duseja, Arka De, Sunil Taneja, et al.
Pageof 15